Israel: Co-founder and ex-CEO leaves board of directors at SHL Telemedicine
Elon Shalev has stepped down from his duties as a member of the board of directors at Swiss listed SHL Telemedicine, a provider and...
Sweden: Oncopeptides appoints Monica Shaw to CEO position as company moves to commercialize Pepaxti
Oncopeptides, a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, has appointed Dr Monica Shaw as Chief Executive Officer,...
Sweden: Jonas Caspari Bark joins Realheart as CFO
Realheart, which is developing the world's first artificial four-chamber heart, has recruited Jonas Caspari Bark as its new CFO, replacing Andreas Hultdin. He joins...
Israel: Francis to take up CEO role at Teva in January
Teva Pharmaceutical Industries has appointed Richard Francis as president and CEO, effective January 1, 2023. He replaces Kåre Schultz who will retire effective December...
New Zealand: Orion Health appoints Porter CEO after 30 years of Ian McCrae
Orion Health, the global health information technology provider, has appointed Brad Porter to take over the CEO role from Ian McCrae later in August....
Sweden: Saga Diagnostics appoints new director of operations
Lund-based precision oncology genomics testing company Saga Diagnostics has appointed Johanna Asklin as director of operations.
Asklin has over 12 years’ experience in commercial project...
Nordics: Humana begins search for new CFO as Jayasekara departs
Noora Jayasekara is leaving Humana after serving the last two years as CFO and as a member of the group’s management. The company will...
Switzerland: C-level changes at Opterion Health
Opterion Health, a Swiss-based life sciences company developing the first major innovation in peritoneal dialysis (PD) for two decades, has named Peter Reinemer as...
New Zealand: Metlifecare poaches Oceania chief executive
In a move that has shaken up the normally staid world of aged care in New Zealand, Oceania Healthcare’s Earl Gasparich will replace Glen...
Norway: Nordic Nanovector replaces CEO as part of restructuring
Oslo-listed Nordic Nanovector, a developer of therapies to address major unmet medical needs and advance cancer care, has consolidated its senior leadership team following...
©2023 All rights reserved LaingBuisson 
